Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus

full text is not available in portal

Category:: Magazine publication
Type:: Magazine publication
Published in:: JOURNAL OF CLINICAL PHARMACOLOGY no. 50, edition 5, pages 494 - 506,
ISSN: 0091-2700
ISSN:: 00912700
Publication year:: 2010
DOI:: Digital Object Identifier (open in new tab) 10.1177/0091270009349376
Verified by:: No verification

seen 52 times

Search